Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von B P Norman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Alkaptonuria, Homogentisic Acid, Disease Models, Animal, Nitrobenzoates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alkaptonuria Society.
Abstract (Originalsprache)
Altered activity of specific enzymes in phenylalanine‐tyrosine (phe‐tyr) metabolism results in incomplete breakdown of various metabolite substrates in this pathway. Increased biofluid concentration and tissue accumulation of the phe‐tyr pathway metabolite homogentisic acid (HGA) is central to pathophysiology in the inherited disorder alkaptonuria (AKU). Accumulation of metabolites upstream of HGA, including tyrosine, occurs in patients on nitisinone, a licenced drug for AKU and hereditary tyrosinaemia type 1, which inhibits the enzyme responsible for HGA production. The aim of this study was to investigate the phe‐tyr metabolite content of key biofluids and tissues in AKU mice on and off nitisinone to gain new insights into the biodistribution of metabolites in these altered metabolic states. The data show for the first time that HGA is present in bile in AKU (mean [±SD] = 1003[±410] μmol/L; nitisinone‐treated AKU mean [±SD] = 45[±23] μmol/L). Biliary tyrosine, 3(4‐hydroxyphenyl)pyruvic acid (HPPA) and 3(4‐hydroxyphenyl)lactic acid (HPLA) are also increased on nitisinone. Urine was confirmed as the dominant elimination route of HGA in untreated AKU, but with indication of biliary excretion. These data provide new insights into pathways of phe‐tyr metabolite biodistribution and metabolism, showing for the first time that hepatobiliary excretion contributes to the total pool of metabolites in this pathway. Our data suggest that biliary elimination of organic acids and other metabolites may play an underappreciated role in disorders of metabolism. We propose that our finding of approximately 3.8 times greater urinary HGA excretion in AKU mice compared with patients is one reason for the lack of extensive tissue ochronosis in the AKU mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
- School of Sport & Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
- Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK.
ORCID-Profile: B P Norman
Förderung
- Alkaptonuria Society
Zitieren
APA
Norman, B. P., Sutherland, H., Wilson, P. J. M., Rutland, D. A., Milan, A. M., Hughes, A. T., Davison, A. S., Khedr, M., Jarvis, J. C., Gallagher, J. A., Bou-Gharios, G., & Ranganath, L. R. (2024). Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12728
Vancouver
Norman BP, Sutherland H, Wilson PJM, Rutland DA, Milan AM, Hughes AT, et al. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12728
BibTeX
@article{Norman2024,
author = {Norman, B P and Sutherland, H and Wilson, P J M and Rutland, D A and Milan, A M and Hughes, A T and Davison, A S and Khedr, M and Jarvis, J C and Gallagher, J A and Bou-Gharios, G and Ranganath, L R},
title = {Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12728}
}
EUVIMED